Earnings Feed
Start Free
|4May 28, 7:01 PM ET

PHARMACYCLICS INC 4

4 · PHARMACYCLICS INC · Filed May 28, 2015

Insider Transaction Report

Form 4
Period: 2015-05-26
PHARMACYCLICS INCPCYC
Booth Robert F.
Director
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−10,000→ 0 total
    Exercise: $5.76Exp: 2020-12-09→ Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−2,126→ 0 total
    Exercise: $10.58Exp: 2021-07-01→ Common Stock (2,126 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−800→ 0 total
    Exercise: $28.47Exp: 2022-04-02→ Common Stock (800 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−442→ 0 total
    Exercise: $65.56Exp: 2022-10-01→ Common Stock (442 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−425→ 0 total
    Exercise: $61.44Exp: 2023-01-02→ Common Stock (425 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,750→ 0 total
    Exercise: $95.08Exp: 2024-05-09→ Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−224→ 0 total
    Exercise: $108.44Exp: 2024-01-02→ Common Stock (224 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−205→ 0 total
    Exercise: $139.89Exp: 2023-10-01→ Common Stock (205 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−240→ 0 total
    Exercise: $107.42Exp: 2024-04-01→ Common Stock (240 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−294→ 0 total
    Exercise: $124.46Exp: 2025-01-02→ Common Stock (294 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−440→ 0 total
    Exercise: $59.28Exp: 2022-07-02→ Common Stock (440 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,500→ 0 total
    Exercise: $14.26Exp: 2021-12-15→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−1,754→ 0 total
    Exercise: $15.02Exp: 2022-01-03→ Common Stock (1,754 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,750→ 0 total
    Exercise: $74.48Exp: 2023-05-09→ Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−20,000→ 0 total
    Exercise: $5.81Exp: 2020-12-31→ Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−1,989→ 0 total
    Exercise: $11.31Exp: 2021-10-03→ Common Stock (1,989 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,500→ 0 total
    Exercise: $49.00Exp: 2022-11-09→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Common Stock

    2015-05-26$261.25/sh−10,000$2,612,500→ 0 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,743→ 0 total
    Exercise: $6.01Exp: 2021-04-01→ Common Stock (3,743 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−307→ 0 total
    Exercise: $79.67Exp: 2023-04-01→ Common Stock (307 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−322→ 0 total
    Exercise: $85.39Exp: 2023-07-01→ Common Stock (322 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−424→ 0 total
    Exercise: $89.58Exp: 2024-07-01→ Common Stock (424 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−314→ 0 total
    Exercise: $115.80Exp: 2024-10-01→ Common Stock (314 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−158→ 0 total
    Exercise: $257.01Exp: 2025-04-07→ Common Stock (158 underlying)
Footnotes (2)
  • [F1]Represents shares issuable pursuant to a Restricted Stock Unit Award that was cancelled in exchange for a cash payment, subject to applicable withholding taxes and pursuant to the procedures terms set forth in the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie.
  • [F2]This option was cancelled pursuant to the terms of the Merger Agreement in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION